<DOC>
	<DOCNO>NCT00112216</DOCNO>
	<brief_summary>The purpose study test whether vaccination antigenic peptide induces immune response vaccine site sentinel lymph node patient microscopically detectable lymph node melanoma metastasis .</brief_summary>
	<brief_title>Immunotherapy Melanoma Patients</brief_title>
	<detailed_description>The study design patient skin melanoma lymph node micrometastasis previously diagnose sentinel node procedure . As result diagnosis , patient schedule lymph node dissection . Before do , patient vaccinate antigenic peptide . The peptide mixed adjuvant SB AS-2 Montanide inject low limb affect disease . The skin site vaccine injection mark permanent pen , two week later , patent blue 99technetium injected . These marker allow one locate vaccine site sentinel node ( VSSN ) remove lymph node dissection diseased limb . The aim study test whether vaccine induce immune response lymph node drain vaccine site .</detailed_description>
	<mesh_term>Melanoma</mesh_term>
	<criteria>Patients microscopically detectable lymph node metastasis Positive detection MelanA gene +/ MAGE10 positive sentinel node primary tumor tissue polymerase chain reaction ( PCR ) analysis mRNA and/or immunohistochemistry use monoclonal antibody Human leukocyte antigenA2 ( HLAA2 ) positive Previous splenectomy radiotherapy spleen Treatment systemic antihistamine , corticosteroid , nonsteroidal antiinflammatory drug ( except occasional low dose nonsteroidal antiinflammatory drug 100 mg aspirin/day ) within 4 week entry study Heart disease ( New York Heart Association [ NYHA ] Class III IV ) Serious illness , e.g . active infection require antibiotic , bleed disorder disease consider investigator potential interfering obtain accurate result study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2009</verification_date>
	<keyword>Immunotherapy</keyword>
	<keyword>Vaccination</keyword>
	<keyword>Melanoma</keyword>
	<keyword>Melan-A/Mart-1 peptide</keyword>
	<keyword>Flu peptide</keyword>
	<keyword>Mage-A10 peptide</keyword>
	<keyword>SB AS-2 adjuvant</keyword>
	<keyword>Montanide adjuvant</keyword>
</DOC>